Entrar

Chapter 17

Pharmacotherapy of the Epilepsies

Artérias dos membros inferiores
Artérias dos membros inferiores
Epilepsy is a chronic neurological disorder characterized by recurrent, unpredictable seizures. Seizures result from abnormal electrical discharges in the ...
Convulsões: Classificação
Convulsões: Classificação
Epilepsy is a chronic neurological disorder characterized by unpredictable seizures. Seizures can be provoked by identifiable factors or occur ...
Drogas antiepilépticas: bloqueadores dos canais de sódio
Drogas antiepilépticas: bloqueadores dos canais de sódio
Antiepileptic drugs, essential in managing epilepsy, effectively prevent seizures by blocking the movement of sodium ions through channels in the ...
Drogas antiepilépticas: potencializadores da via GABAérgica
Drogas antiepilépticas: potencializadores da via GABAérgica
γ-aminobutyric acid or GABA pathway potentiators are drugs used to manage epilepsy by enhancing GABA neurotransmission, a critical inhibitory pathway ...
Drogas antiepilépticas: bloqueadores dos canais de cálcio
Drogas antiepilépticas: bloqueadores dos canais de cálcio
Calcium channel blockers, primarily known for cardiovascular use, have also shown potential as antiepileptic drugs. They exert their effects by modulating ...
Drogas antiepilépticas: antagonistas do glutamato
Drogas antiepilépticas: antagonistas do glutamato
Glutamate is the primary excitatory neurotransmitter in the brain, essential for neuronal communication. It plays a crucial role in synaptic transmission, ...
Drogas Antiepilépticas: Moduladores da Liberação de Neurotransmissores Mediada pela Proteína SV2A
Drogas Antiepilépticas: Moduladores da Liberação de Neurotransmissores Mediada pela Proteína SV2A
Antiepileptic drugs, like levetiracetam and brivaracetam, leverage the synaptic vesicle protein SV2A to mitigate seizures. SV2A is a transmembrane ...
Drogas antiepilépticas: ativadores dos canais de potássio
Drogas antiepilépticas: ativadores dos canais de potássio
The Antiepileptic drug ezogabine functions as a potassium channel activator by enhancing transmembrane potassium currents mediated by the KCNQ subtype of ...
JoVE Logo

Privacidade

Termos de uso

Políticas

Pesquisa

Educação

SOBRE A JoVE

Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados